Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mengsha Li
Complete Regression of Cutaneous Metastases With Systemic Immune Response in a Patient With Triple Negative Breast Cancer Receiving P53MVA Vaccine With Pembrolizumab
OncoImmunology
Oncology
Allergy
Immunology
Loss of Long Non-Coding RNA CRRL Promotes Cardiomyocyte Regeneration and Improves Cardiac Repair by Functioning as a Competing Endogenous RNA
Journal of Molecular and Cellular Cardiology
Cardiovascular Medicine
Molecular Biology
Cardiology
Related publications
Prognostic Factors for Triple-Negative Breast Cancer Patients Receiving Preoperative Systemic Chemotherapy
Clinical Breast Cancer
Cancer Research
Oncology
A microRNA Signature Associated With Pathological Complete Response to Novel Neoadjuvant Therapy Regimen in Triple-Negative Breast Cancer
Tumor Biology
Medicine
Cancer Research
Systemic Inflammatory Response Syndrome in a Patient Diagnosed With High Grade Inflammatory Triple Negative Breast Cancer: A Case Report of a Potentially Rare Paraneoplastic Syndrome
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology
Development of a Vaccine Targeting Triple-Negative Breast Cancer
The WNT10B Network Is Associated With Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer
Cancer Research
Cancer Research
Oncology
PIK3CA H1047R Mutation Associated With a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated With Anthracycline-Taxane–Based Neoadjuvant Chemotherapy
Cancer Research and Treatment
Cancer Research
Oncology
Chemotherapy With CMF for Triple-Negative Breast Cancer With Carcinoma Erysipelatoides
JAMA Dermatology
Dermatology
Medicine
Brachyury, a Vaccine Target, Is Overexpressed in Triple-Negative Breast Cancer
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
CIP4 Promotes Metastasis in Triple-Negative Breast Cancer and Is Associated With Poor Patient Prognosis
Oncotarget
Oncology
